Recombinant human interleukin-32γ facilitates macrophage phagocytosis of Streptococcus pneumoniae by activating nuclear factor kappa B-soluble epoxide hydrolase pathway
Journal of Leukocyte Biology · 03.07.2026 · 118 (7)
DOI: 10.1093/jleuko/qiag093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 10.07.2026. Verfasst von Longying Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), No. 98 Fenghuang…. Hauptthemen laut MEDLINE: Epoxide Hydrolases, Macrophages, Streptococcus pneumoniae, Interleukins. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou High-level, Innovative Talents Project.
Abstract (Originalsprache)
Interleukin-32 is recognized as a potent proinflammatory mediator in various infectious contexts; however, its precise contribution to host defense against Streptococcus pneumoniae (S.pn) remains to be fully elucidated. This study demonstrates that S.pn challenge robustly upregulates interleukin-32 expression in human peripheral blood mononuclear cells and THP-1 cells. Functional assays reveal that exogenous recombinant human interleukin-32γ significantly potentiates the phagocytic activity of both murine (RAW 264.7) and human (THP-1-derived) macrophages against S.pn. Mechanistically, recombinant human interleukin-32γ-induced phagocytosis is mediated by the upregulation and secretion of soluble epoxide hydrolase (sEH), a process contingent upon the activation of the nuclear factor κB (NF-κB) signaling pathway. Furthermore, pharmacological inhibition of either NF-κB or sEH effectively abrogates the prophagocytic effects of recombinant human interleukin-32γ, confirming the functional requirement of the NF-κB–sEH axis in this response. Collectively, these results elucidate a novel interleukin-32γ–NF-κB–sEH regulatory cascade that facilitates macrophage-mediated bacterial clearance, thereby identifying a potential therapeutic target for the management of pneumococcal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), No. 98 Fenghuang Road, HuiChuan District, Zunyi, Guizhou Province 563000, China.
- Department of Pediatrics and Child Health, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), No. 98 Fenghuang Road, HuiChuan District, Zunyi, Guizhou Province 563000, Chin…
- Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), No. 98 Fenghuang Road, HuiChuan District, Zunyi, Guizhou Province 563000, China.
ORCID-Profile: Chengmin Deng, Kaifeng Wu
Förderung
- National Natural Science Foundation of China
- Guizhou High-level
- Innovative Talents Project
- Guizhou Provincial Health Commission
- Department of Science and Technology of Guizhou province
- National Key Clinical Specialty Construction Project
Zitieren
APA
Liang, L., Li, T., Zhang, W., Deng, C., Zhang, L., Wu, K., & Yao, S. (2026). Recombinant human interleukin-32γ facilitates macrophage phagocytosis of Streptococcus pneumoniae by activating nuclear factor kappa B-soluble epoxide hydrolase pathway. Journal of Leukocyte Biology, 118(7). https://doi.org/10.1093/jleuko/qiag093
Vancouver
Liang L, Li T, Zhang W, Deng C, Zhang L, Wu K, et al. Recombinant human interleukin-32γ facilitates macrophage phagocytosis of Streptococcus pneumoniae by activating nuclear factor kappa B-soluble epoxide hydrolase pathway. Journal of Leukocyte Biology. 2026;118(7). doi:10.1093/jleuko/qiag093
BibTeX
@article{Liang2026,
author = {Liang, Longying and Li, Tingting and Zhang, Weiwei and Deng, Chengmin and Zhang, Longze and Wu, Kaifeng and Yao, Shifei},
title = {Recombinant human interleukin-32γ facilitates macrophage phagocytosis of Streptococcus pneumoniae by activating nuclear factor kappa B-soluble epoxide hydrolase pathway},
journal = {Journal of Leukocyte Biology},
year = {2026},
volume = {118},
number = {7},
doi = {10.1093/jleuko/qiag093}
}
EUVIMED